Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors

16Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Heterocyclic arotinoids derived from central-region dihalogenated pyrazine scaffolds have been synthesized by consecutive halogen and/or position-selective palladium-catalyzed cross-coupling reactions. Pyrazines were further functionalized as alkyl ethers or methylamines prior to the last Pd-catalyzed reactions. Transient transactivation studies with the retinoic acid receptor (RAR) α, β, and γ subtypes and with retinoid X receptor (RXR) a revealed distinct agonist, antagonist, and inverse agonist activities for these compounds. Of interest are the RARα,β-selective inverse agonists with pyrazine acrylic acid structures, in particular 14c, which is RARβ-selective, and 14d, a pan-RAR/RXR inverse agonist with more affinity for the RAR subtypes that enhance the interaction of RAR with cognate corepressors. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Cite

CITATION STYLE

APA

García, J., Khanwalkar, H., Pereira, R., Erb, C., Voegel, J. J., Collette, P., … de Lera, Á. R. (2009). Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors. ChemBioChem, 10(7), 1252–1259. https://doi.org/10.1002/cbic.200900030

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free